Almonty's Korean Listing Ambitions Meet a 69% Tungsten Slide and a Trimmed Sangdong Timeline

A possible second stock exchange listing is not the same thing as an operational breakthrough. That distinction sits at the heart of the Almonty investment case right now, because two separate narratives are competing for investor attention — and only one of them will ultimately decide whether the shares deserve a higher value.

Media reports on Monday said the company is weighing an additional listing in South Korea, potentially via Korean depositary receipts. The deliberations are just that: considerations, not a resolved decision. Treating them as a secured advantage for the stock would be premature, since any benefit would depend on an actual decision and its structure.

Two Yardsticks That Should Stay Apart

Market presence and project delivery answer different questions. A further listing could change where and how the shares trade. Whether Almonty meets its operating expectations, by contrast, is settled at Sangdong — the tungsten project whose ramp-up timetable has become the stock's key proving ground.

The company updated its expectations for Phase I and Phase II at an investor day roughly two weeks ago. What followed from analysts explains why that revision matters more than the prospect of another trading venue. Stifel's Brock Cannon cut his price target to US$21 from US$25 on 20 October, keeping his buy rating intact. His reasoning: revised timing assumptions for both phases and delivery expectations pushed further into the future.

That combination is the crux. A constructive fundamental view offers no protection against a lower valuation when expected shipments are booked later. A listing and a delivery are different events, and they answer different questions.

Should investors sell immediately? Or is it worth buying Almonty?

A Commodity Backdrop That Has Turned

The tungsten price has added a second layer of pressure. According to media reports, the Chinese price for the intermediate product APT stood at 470,000 yuan per tonne on 15 October — a decline of roughly 69% from the mid-March high. The report described a broad correction across tungsten prices.

That reframes the Sangdong debate. Operating progress and a favourable price environment are not the same thing, and a thesis built mainly on individual delivery milestones looks thin against a sliding commodity tape. Reports from 20 October noted that tungsten had surrendered a large part of this year's rally. No verified explanation for any single day's move in Almonty shares follows from that, but for the risk case the point stands: weaker sector sentiment would not offset additional operational uncertainty.

Where the Long-Run Case Still Rests

A longer-dated marker came from Diamond Equity Research on 21 October. The analysis — commissioned and paid for by Almonty, a relationship that belongs explicitly in any assessment of it — projected completion of Phase II in 2027. That remains an expectation, not a guaranteed outcome.

Should that outlook firm up, a Korean listing could be read as a complement to a project genuinely moving forward. The bullish scenario does not require the Korea option to trigger a re-rating on its own. More convincing would be a combination: Almonty fleshes out the listing plans while operational progress confirms the revised Sangdong expectations. Then the capital-markets story would not have to fight doubts about the schedule.

The unchanged buy rating at Stifel, despite the target cut, illustrates at least that later delivery assumptions do not automatically rule out a broadly positive view. A positive recommendation and a more cautious valuation can coexist. For investors, the direction of the adjustment matters at least as much as the unchanged label.

What Would Override the Listing Story

The serious counterargument runs like this: a second listing could attract attention while the economically weightier delivery assumptions come under renewed pressure. In that case the Korea angle would not solve the valuation problem — the benchmark would still be when expected operating contributions actually draw nearer.

Wednesday's 5.1% decline fits the more cautious picture but proves neither an additional operational setback nor a direct link to any single analyst decision. Nor should every share-price move be pinned to a headline.

The next potential catalyst would be clarity on the Korean listing — specifically whether Almonty is merely exploring an option or announcing a more binding step. In parallel, the expected Phase II completion in 2027 remains an operating reference point rather than a promised result. The investment case does not hinge on whether the Korea idea sounds appealing. It hinges on whether added market presence meets more dependable project progress. Only that pairing would turn two separate stories into a more persuasive whole.

Ad

Almonty Stock: New Analysis - 29 October

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...